Every round on record, with the sources behind each and the investors on them.
Provider of an emergency ventilation monitoring platform
archeon-medical.comLinkedInBesancon, FranceHealthtechFounded 201825 employees
7 sources · checked 3 times, last 8h ago
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series A | $9M | 2026-10-06 | Newfund, through its HEKA fund | 7 outlets. #61 in Trending |
7 sources · checked 3 times, last 8h ago [ VERIFIED · CORRECTED ] read against 4 of 7 sources
| ||||
Archeon Medical builds EOlife ventilation-feedback devices that help first-aid and emergency medical teams deliver better manual ventilation during life-threatening emergencies.
Archeon is addressing a critical gap in cardiac-arrest care: manual ventilation is often delivered without objective feedback even though ineffective ventilation can worsen survival and neurological outcomes. Its 2026 $9M (€7.5M) Series A is intended to fund clinical studies involving more than 1,500 patients and accelerate US commercialization, building on EOlife use by emergency services, hospitals and training organizations worldwide.
Checked against 10 sources yesterday
Also named as backers in company research: Newfund, HEKA fund, OSER BFC fund, Bpifrance, Daphni, European Regional Development Fund (ERDF - European Social Fund for Franche-Comté and Massif du Jura), European Commission